ArticlePhysical and engineering sciences in medicine2026
Early predicting brain metastases of EGFR positive lung adenocarcinoma patients by CT radiomics.
Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Early prediction of brain metastases (BM) in epidermal growth factor receptor (EGFR) positive lung adenocarcinoma patients is critical for improving treatment strategies and prognosis. This study aimed to enhance BM risk prediction within two years for lung adenocarcinoma patients by using lung CT images and clinical data both derived from initial diagnosis. This study comprised 173 patients with EGFR positive lung adenocarcinoma who underwent diagnostic CT and was stratified into 93 patients with BM and 80 patients without BM. We extracted a total of 1334 radiomic features from each manually delineated primary pulmonary nodule. Least absolute shrinkage and selection operator (LASSO) method was applied to select the optimal image features. Subsequently, the clinical model, radiomic model and hybrid model were constructed employing logistic regression, random forest (RF), support vector machine (SVM), and light gradient boosting machine (LGBM) algorithms separately. Ultimately, the model was evaluated and interpreted utilizing the receiver operating characteristic (ROC) curve, decision curve analysis (DCA), and shapley additive explanations (SHAP). The hybrid model consistently exhibited superior predictive performance. Specifically, the logistic regression-based hybrid model exhibited the highest overall performance metrics, with an AUC of 0.94 (95% CI 0.81-0.99). This study demonstrates that the logistic regression-based hybrid model can effectively predict BM in EGFR positive lung adenocarcinoma patients at their initial diagnosis, aiding physicians in developing more accurate treatment plans.
Indexed as
Identifiers
41288929What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.